The Online Investor
Medical Instruments & Supplies M&A image Medical Instruments & Supplies M&A » By The Online Investor Staff, updated Fri., Apr. 26, 7:38 PM Recent mergers and acquisitions in the Medical Instruments & Supplies M&A category.

Slide #72. Trinity Biotech plc Immco Diagnostics Inc.

Acquirer: Trinity Biotech plc (NASDAQ:TRIB)
Acquiree: Immco Diagnostics Inc.
Details: Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2013 and the acquisition of Immco Diagnostics Inc.

Trinity Biotech develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Co. is also a provider of raw materials to the life sciences and research industries globally. Co. markets its portfolio of products to customers through its own sales force and a network of international distributors and partners. The brand names of the products of Co. include UniGold, Recombigen, MarDx, FlexTrans, Premier, Ultr, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot, EZ, and Captia.

Open the TRIB Page at The Online Investor »

Company Name: 
Trinity Biotech Plc
Website: 
www.trinitybiotech.com
Sector: 
Biotechnology
 

Open the TRIB Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree TRIB Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Medical Instruments & Supplies M&A - Slide 72 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.